Novel Therapies for Preeclampsia
| dc.authorscopusid | 58185850600 | |
| dc.authorscopusid | 56730281100 | |
| dc.authorscopusid | 57192008817 | |
| dc.authorscopusid | 50361476100 | |
| dc.authorscopusid | 42262158200 | |
| dc.authorscopusid | 57210469670 | |
| dc.authorscopusid | 57210469670 | |
| dc.contributor.author | Mousavi, S.N. | |
| dc.contributor.author | Rapisarda, A.M.C. | |
| dc.contributor.author | Kahramanoglu, O. | |
| dc.contributor.author | Lin, L.-T. | |
| dc.contributor.author | Karaman, E. | |
| dc.contributor.author | Arcidiacono, G. | |
| dc.contributor.author | Fichera, M. | |
| dc.date.accessioned | 2025-05-10T16:43:47Z | |
| dc.date.available | 2025-05-10T16:43:47Z | |
| dc.date.issued | 2020 | |
| dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
| dc.department-temp | Mousavi S.N., Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy; Rapisarda A.M.C., Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy; Kahramanoglu O., Department of Perinatology, Health Science University, Zeynep Kamil Women and Children’s Diseases Training and Research Hospital, Istanbul, Turkey; Lin L.-T., Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan; Karaman E., Department of Obstetric and Gynecology, Van Yuzuncu Yil University, Van, Taiwan; Arcidiacono G., Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy; Fichera M., Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy | en_US |
| dc.description.abstract | Preeclampsia is a serious condition that has complicated pregnancies for centuries. The angiogenic imbalance is a hallmark of preeclampsia, and angiogenic markers have proved to be effective tools for early diagnosis and prognosis of affected pregnancies. The only effective treatment for preeclampsia remains delivery, but novel therapies are being developed to ameliorate complications and prolong gestation. The aim of this chapter is to provide an updated overview of the most recent innovations and discoveries in the field of the treatment of preeclampsia. © 2020 by Nova Science Publishers, Inc. All rights reserved. | en_US |
| dc.identifier.endpage | 214 | en_US |
| dc.identifier.isbn | 9781536186321 | |
| dc.identifier.isbn | 9781536185188 | |
| dc.identifier.scopus | 2-s2.0-85152669100 | |
| dc.identifier.scopusquality | N/A | |
| dc.identifier.startpage | 177 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.14720/291 | |
| dc.identifier.wosquality | N/A | |
| dc.language.iso | en | en_US |
| dc.publisher | Nova Science Publishers, Inc. | en_US |
| dc.relation.ispartof | Preeclampsia: Diagnosis, Treatment Andmanagement | en_US |
| dc.relation.publicationcategory | Kitap Bölümü - Uluslararası | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Novel Therapies for Preeclampsia | en_US |
| dc.type | Book Part | en_US |